New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 18, 2012
06:01 EDTAPRIApricus Biosciences receives $2.5M payment from Abbott Laboratories for Vitaros
Apricus Biosciences announced that it received a $2.5M payment from Abbott Laboratories Limited under its commercial partnership for Apricus Bio's Vitaros drug for erectile dysfunction, in Canada. Also, Apricus Bio successfully produced six consecutive commercial size validation batches of Vitaros, the company's treatment for ED in 220 mcg and 330 mcg forms.
News For APRI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 16, 2015
07:08 EDTAPRIApricus Biosciences sees current cash will support operating plan through 2015
Subscribe for More Information
07:07 EDTAPRIApricus Biosciences reports Q4 EPS (40c), may not compare to consensus (12c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use